At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NCT06937814N/ARecruitingMonitorUpdated 3mo ago · Completion was 3mo agoThe Effect of Humiome® Post LB on Gut COMFort in healthY Adult Volunteers: a Double-blind, Randomized Placebo-controlled Study
In Brief
A clinical study evaluating Humiome ® Post LB and Placebo for GI Issues and 2 related conditions. Currently recruiting, targeting 250 participants across 1 site.
Signals
Detailed Summary
The goal of this double-blind, randomized placebo-controlled study is to evaluate the effect of an 8-week supplementation of Humiome ® Post LB (170 mg) on bowel movements in healthy adult volunteers compared to Placebo adjusted on baseline. The main question\[s\] it aims to answer \[is/are\]: Does Humiome ® Post LB improve bowel movements with self-reported GI issues? Participants will be provided Humiome ® Post LB (170 mg) for 8 weeks and asked to complete a study diary, questionnaires, and stool samples.
Study Details
Timeline
Interventions
Participants will be instructed to take one capsule with a glass of water after the first meal of the day.
Participants will be instructed to take one capsule with a glass of water after the first meal of the day.